FT News Briefing cover image

Big Pharma markets left on a ‘patent cliff’-hanger

FT News Briefing

00:00

Navigating the Intersection of Shareholder Lawsuits and Patent Challenges in Pharma

This chapter examines the intricacies of shareholder lawsuits and their varying impacts on companies incorporated in Delaware and Nevada. It also addresses the pharmaceutical sector's struggles with patent expirations, emphasizing the challenges faced by major players like Merck.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app